Bridges Investment Counsel Has Lowered Merck & Co Com (MRK) Holding; RGC Resources (RGCO) Has 1.25 Sentiment

RGC Resources, Inc., through its subsidiaries, operates as an energy services company. The company has market cap of $180.28 million. The firm sells and distributes natural gas to residential, commercial, and industrial clients in Roanoke, Virginia, and the surrounding localities. It has a 29.87 P/E ratio. It also provides various unregulated services.

Bridges Investment Counsel Inc decreased Merck & Co Inc Com (MRK) stake by 63.77% reported in 2017Q3 SEC filing. Bridges Investment Counsel Inc sold 27,669 shares as Merck & Co Inc Com (MRK)’s stock declined 2.46%. The Bridges Investment Counsel Inc holds 15,721 shares with $1.01 million value, down from 43,390 last quarter. Merck & Co Inc Com now has $149.29B valuation. The stock increased 0.02% or $0.01 during the last trading session, reaching $55.37. About 11.71 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since March 14, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Since January 1, 0001, it had 9 insider buys, and 0 selling transactions for $11,291 activity.

Analysts await RGC Resources, Inc. (NASDAQ:RGCO) to report earnings on May, 7. They expect $0.50 EPS, up 11.11% or $0.05 from last year’s $0.45 per share. RGCO’s profit will be $3.63 million for 12.41 P/E if the $0.50 EPS becomes a reality. After $0.25 actual EPS reported by RGC Resources, Inc. for the previous quarter, Wall Street now forecasts 100.00% EPS growth.

The stock decreased 6.97% or $1.86 during the last trading session, reaching $24.82. About 37,698 shares traded or 331.03% up from the average. RGC Resources, Inc. (RGCO) has risen 62.35% since March 14, 2017 and is uptrending. It has outperformed by 45.65% the S&P500.

Dixon Hubard Feinour & Brown Inc Va holds 0.59% of its portfolio in RGC Resources, Inc. for 72,338 shares. Fca Corp Tx owns 35,415 shares or 0.42% of their US portfolio. Moreover, Trust Co Of Virginia Va has 0.23% invested in the company for 55,092 shares. The New York-based Dalton Greiner Hartman Maher & Co has invested 0.22% in the stock. North Star Investment Management Corp., a Illinois-based fund reported 58,387 shares.

Investors sentiment decreased to 0.94 in 2017 Q3. Its down 0.12, from 1.06 in 2017Q2. It fall, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Citigroup invested in 0.13% or 2.43M shares. Beach Invest Counsel Pa reported 80,128 shares. Norinchukin Savings Bank The owns 375,312 shares. King Luther Capital Mgmt has 1.68 million shares for 0.94% of their portfolio. Moreover, Douglass Winthrop Advisors Ltd Liability has 1.12% invested in Merck & Co., Inc. (NYSE:MRK) for 300,328 shares. Hardman Johnston Glob Limited Liability Company holds 0.04% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 13,150 shares. Moreover, Paw Capital has 0.74% invested in Merck & Co., Inc. (NYSE:MRK) for 11,000 shares. Argent Trust Company holds 71,599 shares or 1.26% of its portfolio. Orbimed Lc holds 5.49M shares or 3.36% of its portfolio. Ims Cap Management has 10,718 shares. Weatherly Asset Mgmt Ltd Partnership has invested 0.12% in Merck & Co., Inc. (NYSE:MRK). Wg Shaheen & Associate Dba Whitney & owns 83,595 shares. Guinness Atkinson Asset Mngmt Incorporated holds 0.15% or 3,810 shares in its portfolio. 11,853 were accumulated by Institute For Wealth Mngmt Ltd Liability Corporation. Westpac Corporation stated it has 0.36% of its portfolio in Merck & Co., Inc. (NYSE:MRK).

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1. They expect $0.99 earnings per share, up 12.50% or $0.11 from last year’s $0.88 per share. MRK’s profit will be $2.67B for 13.98 P/E if the $0.99 EPS becomes a reality. After $0.98 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.02% EPS growth.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 18 have Buy rating, 0 Sell and 6 Hold. Therefore 75% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $65.28’s average target is 17.90% above currents $55.37 stock price. Merck & Co. Inc. had 81 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was upgraded by Citigroup on Monday, October 30 to “Buy”. BMO Capital Markets maintained the shares of MRK in report on Friday, July 28 with “Buy” rating. The firm has “Outperform” rating by Credit Suisse given on Monday, February 5. BMO Capital Markets maintained it with “Buy” rating and $7200 target in Friday, August 4 report. The company was upgraded on Thursday, August 13 by BMO Capital Markets. The rating was initiated by Societe Generale on Wednesday, September 30 with “Hold”. BMO Capital Markets downgraded Merck & Co., Inc. (NYSE:MRK) on Monday, July 18 to “Market Perform” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Hold” rating given on Thursday, August 27 by Berenberg. As per Thursday, January 12, the company rating was upgraded by Guggenheim. On Friday, August 18 the stock rating was maintained by Jefferies with “Sell”.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: